MedTrace Logo

Home-Based Program to Treat High Blood Pressure in African Americans

NCT00139490 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 846

Last updated 2012-12-21

No results posted yet for this study

Summary

The purpose of this study is to examine the effectiveness and cost effectiveness of two organizational interventions aimed at improving blood pressure (BP) control among a high-risk, African American home care population.

Conditions

Interventions

BEHAVIORAL

Health Education Program

The augmented intervention will consist of just-in-time nurse, patient and physician information and feedback during the post-acute period, plus transition to an ongoing Home-Based HTN Support Program within approximately 30 days after the patient's admission to home health care. The augmented intervention adds an HTN Nurse Specialist (advanced practice nurse) and a lay community health worker, who will be responsible for assuring a patient's smooth transition to the Home-Based HTN Support Program and for delivering the main components of that intervention, backed up by the project physician.

BEHAVIORAL

Basic Group

The basic information and referral intervention will deliver key "just-in-time" information to nurses, patients and patients' physicians while the patient is receiving post-acute home care services. The basic intervention relies on care provided by home health nurses during the routine home health stay.

BEHAVIORAL

Control Group

Usual Care

Sponsors & Collaborators

  • Visiting Nurse Service of New York

    lead OTHER

Principal Investigators

  • Penny H. Feldman, PhD · Center for Home Care Policy & Research, Visiting Nurse Service of New York

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-02-28
Primary Completion
2009-05-31
Completion
2009-09-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00139490 on ClinicalTrials.gov